Immatics N.V. Ordinary Shares (IMTX)
Immatics N.V. Ordinary Shares
XNAS:IMTX
9.91
$11.37 - 100.00
$8.79 - 100.00
$9.76
$10.1
$10.1
$10.15
12.41
3.3
281040
341200.3
108468769.25
Chart
TendieTensor AI Analysis
Company
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Fundamentals
423
-9.060000
2.460580
100
121.55M
121.56M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own IMTX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.